Induced hypertrophy by Angiotensin II (Ang II) administration in human cardiomyocytes revealed the downregulation of NRB2 as well as an increased level of cardiac hypertrophy markers such as ANF or BMP10. The gene discussed is AGT; the disease is cardiac hypertrophy.